FindTrial
Sign In

see above

see above

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002730-19-IT
Enrollment
Unknown
Registered
2005-02-14
Start date
2005-01-26
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus MedDRA version: 6.1 Level: HLT Classification code 10012602

Interventions

Trade Name: LANTUS*SC 5CART 3ML 100UI/ML Product Name: GLARGINE Pharmaceutical Form: Solution for injection INN or Proposed INN: Insulin glargine Current Sponsor code: HOE 901/3509 Concentration u

Sponsors

AVENTIS PHARMA S.P.A.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026